Analystreport

Kala Pharmaceuticals Inc (NASDAQ: KALA) was upgraded by analysts at Bank of America Corp from a "neutral" rating to a "buy" rating.

Kala Pharmaceuticals, Inc.  (KALA) 
Last kala pharmaceuticals, inc. earnings: 2/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.kalarx.com